Chicago Atlantic BDC Q2 2026: Merger with REFI Advances, REFI Raises $62.5M in Private Placement
LIEN is trading near its 52-week low of $8.92 (4.4% above the low) on light trading volume (0.4× avg).
Summary
Chicago Atlantic BDC's Q2 2026 10-Q shows the REFI merger on track for Q4 2026, with REFI raising $62.5M in a private placement that will impact the exchange ratio. The company also filed its N-14 and declared a $0.34 dividend.
Key Events · M&A and Partnerships · LIEN
-
REFI Private Placement Alters Exchange Ratio
On July 9, 2026, REFI issued 4,306,754 shares at $14.53 per share in exchange for $62.5M of second lien notes. This increases REFI's share count and will be reflected in the Closing REFI NAV, directly impacting the Exchange Ratio for the merger.
-
Merger Progresses Toward Q4 2026 Close
The company filed its Form N-14 registration statement on July 31, 2026, containing the preliminary joint proxy statement. Stockholder votes and regulatory approvals remain outstanding, with closing expected in Q4 2026.
-
Quarterly Dividend Declared
The Board approved a $0.34 per share cash dividend on August 10, 2026, payable October 9, 2026 to stockholders of record on September 25, 2026.
-
Merger Transaction Costs
The company's allocable share of merger transaction costs was approximately $1.3 million, of which $0.8 million remained unpaid as of June 30, 2026. These costs are deferred and will be capitalized upon closing.
Analysis · LIEN · Unknown
Chicago Atlantic BDC's Q2 2026 10-Q confirms the pending merger with Chicago Atlantic Real Estate Finance (REFI) is progressing toward a Q4 2026 close. The filing reveals a new material development: REFI issued 4.3 million shares at $14.53 per share in a July 9 private placement, raising approximately $62.5 million in exchange for second lien notes. This transaction will directly affect the Exchange Ratio used to determine how many LIEN shares REFI stockholders receive, potentially altering the ownership split of the combined company. The company also filed its Form N-14 registration statement on July 31, a key regulatory step toward the stockholder votes. The stock trades at $9.31, a 30% discount to its $13.26 net asset value per share, reflecting market uncertainty about the merger's completion and the cannabis lending portfolio's credit quality.
At the time of this filing, LIEN was trading at $9.31 on NASDAQ in the Unknown sector, with a market capitalization of approximately $222M. The 52-week trading range was $8.92 to $11.44. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.